Jpmorgan Chase & Co »

Viking Therapeutics Inc put shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Viking Therapeutics Inc put shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Viking Therapeutics Inc put

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics Inc put held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics Inc put by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $10M 160k 63.31
2023-12-31 $134k 7.2k 18.61
2023-09-30 $80k 7.2k 11.07
2023-06-30 $14M 845k 16.21
2019-12-31 $1.6M 194k 8.02
2019-09-30 $1.3M 194k 6.88
2019-06-30 $1.9M 222k 8.37
2019-03-31 $2.6M 259k 9.94
2018-09-30 $523k 30k 17.43

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Viking Therapeutics Inc put

Jpmorgan Chase & Co
Simplex Trading
Group One Trading
Worth Venture Partners

View all funds holding Viking Therapeutics Inc put